International Money Express, Inc., known by its Intermex brand, is a Miami-based omnichannel money-remittance company serving corridors from the United States to Latin America, the Caribbean, and other regions. Because this is an acquisition-driven situation rather than a conventional growth story, standard analyst price targets offer limited signal. The "$16" figure that appears on data aggregators as the consensus is effectively the Western Union offer, not an independent fundamental estimate.
Among identifiable, dated research, Monness reiterated a Hold rating with a $13.00 price target in late July 2026. Before the deal was announced, Street targets sat higher—aggregator data points to a roughly $19.60 consensus a year earlier, with individual targets ranging from about $11 to $20 in 2025. Today the range of genuinely current, independent targets is too narrow and too deal-anchored to form a meaningful aggregate. For that reason, the $16 central target used here is the acquisition price, clearly identified as a public-market objective rather than an analyst consensus. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
With the stock near $7.34 as of its most recent verified close, reaching $16 would require a gain of roughly 118%—a very large move by any standard. The path is binary rather than gradual. Western Union agreed in August 2025 to acquire Intermex for $16.00 per share in cash, valuing the company at roughly $500 million. If the deal closes, the share price converges on $16 as a matter of contract, not trading.
That convergence has not happened because the transaction is mired in regulatory uncertainty. California's Department of Financial Protection and Innovation suspended its approval in August 2026, and the parties faced a November 6 walk date under which either side could exit without penalty. The steep discount—the shares traded near $11.50 in October before sliding further—reflects the market's assessment that the deal may not complete, rather than any read on Intermex's fundamentals.
The clearest support is the offer itself: a binding, all-cash $16 bid creates a capped, contractual path to the target if approvals are secured. New York's financial regulator approved the transaction in August 2026, and the companies have cleared most U.S. state jurisdictions. A reinstatement of California's approval, or completion of the renewed federal antitrust review, would likely narrow the gap to the offer rapidly.
A secondary, standalone rationale exists in valuation discussions. GuruFocus's proprietary GF Value estimate for IMXI has ranged between roughly $17 and $18 across 2026, implying the shares trade below an intrinsic-value benchmark. That is a directional signal, not a forecast, and it depends heavily on assumptions about a business whose earnings have weakened.
The primary obstacle is regulatory and political. California's suspended review, reportedly influenced by new agency leadership and a harder line on consolidation in consumer finance, has already pushed the deal past its original mid-2026 closing target. If the walk date passes without completion and either party exits, the $16 objective disappears, and the stock would be valued purely on standalone merits.
Those standalone merits have deteriorated. In the first half of 2026, Intermex's revenue declined roughly 17% year over year to about $253 million, while net income fell by roughly 75%. The business faces structural pressure from the shift of remittances toward digital channels, a new U.S. tax on cash remittances, and tighter immigration enforcement—headwinds that affect both Intermex and its prospective acquirer.
IMXI's chart tells a story of broken support. The shares have a 52-week range of roughly $7.00 to $15.95, and the latest close near $7.34 sits just above the lower bound. The October slide from about $11.50 through the low-teens marked a decisive breakdown below the levels where the stock had traded while investors awaited the deal. On the upside, the $11.50-to-$12 zone—where the shares consolidated during the fall—now represents a potential resistance area, while $16 functions as the hard ceiling implied by the offer price.
Unlike a conventional 12-month analyst target, the $16 objective has a near-term, event-driven horizon tied to deal milestones. Investors should monitor whether California reinstates its approval, whether the federal antitrust waiting period clears, and whether either company exercises its right to walk away. Intermex's quarterly results—and Western Union's commentary on the transaction—remain important, as continued earnings erosion would further pressure any standalone valuation. Regulatory headlines, rather than earnings revisions, are likely to drive the stock in the near term.
In my analysis of event-driven names like this, I often rely on Tickeron’s AI Daily Buy/Sell Signals to track shifting conditions. The system applies artificial intelligence to monitor thousands of securities and generate Buy, Sell, or Hold signals based on technical behavior and market data. For a situation that hinges on regulatory updates, this kind of automated insight helps spot trend changes efficiently and manage positions with greater clarity.
The question of whether IMXI can reach $16 is ultimately a question about whether Western Union's acquisition completes. The target is not an analyst forecast but a contractual offer price, and the roughly 118% gap reflects genuine doubt that the deal will close. Support rests on the binding cash offer and progress in other jurisdictions; the obstacles are California's regulatory posture, a lapsed federal review, and a standalone business with sharply declining revenue and profit. Analyst coverage is too thin and too deal-anchored to provide an independent consensus. Investors should watch the approval timeline and walk-date developments above all else—the outcome is event-driven, and no price outcome is guaranteed.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Aroon Indicator for IMXI entered a downward trend on November 06, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 162 similar instances where the Aroon Indicator formed such a pattern. In 125 of the 162 cases the stock moved lower. This puts the odds of a downward move at 77%.
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IMXI as a result. In 55 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.
The Moving Average Convergence Divergence Histogram (MACD) for IMXI turned negative on November 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 36 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 72%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMXI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +10.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMXI advanced for three days, in 155 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
IMXI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 64 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.308) is normal, around the industry mean (16.360). P/E Ratio (11.651) is within average values for comparable stocks, (53.310). Projected Growth (PEG Ratio) (2.738) is also within normal values, averaging (3.696). Dividend Yield (0.000) settles around the average of (0.434) among similar stocks. P/S Ratio (0.720) is also within normal values, averaging (104.492).
The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. IMXI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMXI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a financial conglomerate
Industry ComputerCommunications